Skip to main content
TIANYU BIO-TECHNOLOGY CO.,LTD. logo

TIANYU BIO-TECHNOLOGY CO.,LTD. — Investor Relations & Filings

Ticker · 603717 ISIN · CNE1000030W1 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,621 across all filing types
Latest filing 2025-10-14 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603717

About TIANYU BIO-TECHNOLOGY CO.,LTD.

https://www.tianyubiotech.com/

TIANYU BIO-TECHNOLOGY CO.,LTD. specializes in the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and advanced pharmaceutical intermediates. The company focuses on therapeutic areas such as cardiovascular health, diabetes management, and anti-viral treatments. Its core product portfolio includes various sartan-based intermediates and other complex organic synthesis products. TIANYU BIO-TECHNOLOGY emphasizes rigorous quality management systems and adheres to international regulatory standards to ensure product safety and efficacy. By leveraging advanced chemical synthesis technologies and a robust R&D infrastructure, the company provides customized manufacturing solutions and high-quality chemical components to global pharmaceutical partners. Its operations are characterized by a commitment to technical innovation and process optimization in the synthesis of complex molecules.

Recent filings

Filing Released Lang Actions
上海市锦天城律师事务所关于天域生物科技股份有限公司2025年第四次临时股东大会的法律意见书
Regulatory Filings
2025-10-14 Chinese
2025年9月养殖业务主要经营数据公告
Regulatory Filings Classification · 95% confidence The document is a monthly operating data announcement for September 2025 from Tianyu Bio-Technology Co., Ltd. It provides specific sales volume, sales revenue, and inventory data for the month and cumulative year-to-date figures. The document explicitly states that the data is unaudited and is provided as interim data for investor reference. It does not contain comprehensive financial statements or detailed financial analysis typical of an Interim/Quarterly Report (IR), nor is it a full Annual Report or Earnings Release. The document is short (1244 characters) and serves as a business update on operating metrics rather than a formal financial report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-10-13 Chinese
关于收到《民事判决书》暨诉讼进展公告
Legal Proceedings Report Classification · 95% confidence The document is a public announcement from Tianyu Bio-Tech Co., Ltd. regarding the receipt of a civil judgment and the progress of a litigation case. It details the lawsuit's background, the court's judgment, and the potential impact on the company's profits. The content focuses on legal proceedings and litigation updates rather than financial results, management changes, or shareholder votes. It does not contain financial statements or detailed financial analysis, nor is it a report or presentation. The document is a legal proceedings update related to a lawsuit involving the company. Therefore, it fits best under the category of Legal Proceedings Report (LTR). The document length is 1701 characters, which is relatively short but contains substantive information about the lawsuit and court judgment, not just an announcement of a report publication or a certification. Hence, the classification is LTR with high confidence.
2025-09-30 Chinese
关于股东回馈活动的自愿性信息披露公告
Regulatory Filings Classification · 95% confidence The document is a voluntary information disclosure announcement by the company Tianyu Bio regarding a shareholder appreciation event. It details the event's timing, prizes, participation conditions, and risk warnings. There is no financial data, no report attached or referenced, no regulatory certification, no management or board changes, no voting results, no capital or financing updates, and no legal proceedings. The document is essentially an announcement about a shareholder event and does not fit into any specific financial report category. Therefore, it falls under Regulatory Filings (RNS) as a general announcement that does not fit other categories.
2025-09-29 Chinese
募集资金管理制度（2025年09月修订）
Governance Information Classification · 95% confidence The document is titled '募集资金管理制度' which translates to 'Fundraising Capital Management System' and is a detailed internal policy document outlining the management, storage, usage, supervision, and responsibilities related to the company's raised funds. It references relevant laws and regulations, internal governance, and procedures for handling raised capital. The document is not a financial report, earnings release, or announcement but rather a governance and compliance policy document related to capital management. It does not contain financial statements or results but focuses on rules and procedures for managing raised funds. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices related to capital management.
2025-09-28 Chinese
公司章程（2025年09月修订）
Governance Information Classification · 100% confidence The document is titled as the "章程" (Articles of Association or Company Bylaws) of Tianyu Bio-Technology Co., Ltd. It contains detailed chapters on company organization, shareholder rights, board of directors, management, financial accounting, profit distribution, audit, notices, announcements, mergers, amendments to the articles, and other governance-related provisions. It is a comprehensive internal governance document outlining the company's rules and regulations, rights and obligations of shareholders, board structure, and management responsibilities. There is no indication that this is an annual report, financial statement, earnings release, or any other financial disclosure. Instead, it fits the description of a Governance Information report, which details the company's internal rules, board structure, and governance practices. The document length (15,000 characters) and content confirm it is the full governance charter, not a brief announcement or summary. Therefore, the appropriate classification is Governance Information (CGR).
2025-09-28 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.